Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Zhiyuan Biotechnology is a leading high-tech enterprise specializing in the research, development, and production of cyclodextrin derivatives and inclusion complexes. The company provides a wide range of pharmaceutical excipients, including Hydroxypropyl Betadex and Betadex Sulfobutyl Ether Sodium, which are critical for improving the solubility and stability of active pharmaceutical ingredients. With advanced manufacturing facilities and a strong focus on quality control, Zhiyuan serves global pharmaceutical, food, and cosmetic industries. Their expertise in cyclodextrin chemistry enables the development of customized solutions for drug delivery and formulation challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhiyuan Bioscience.